首页> 美国卫生研究院文献>other >The KCa2 Channel Inhibitor AP14145 But Not Dofetilide or Ondansetron Provides Functional Atrial Selectivity in Guinea Pig Hearts
【2h】

The KCa2 Channel Inhibitor AP14145 But Not Dofetilide or Ondansetron Provides Functional Atrial Selectivity in Guinea Pig Hearts

机译:KCa2通道抑制剂AP14145但不是多非利特或昂丹司琼不能在豚鼠心脏中提供功能性心房选择性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background and Purpose: Prolongation of cardiac action potentials is considered antiarrhythmic in the atria but can be proarrhythmic in ventricles if the current carried by Kv11.1-channels (IKr) is inhibited. The current mediated by KCa2-channels, IKCa, is considered a promising new target for treatment of atrial fibrillation (AF). Selective inhibitors of IKr (dofetilide) and IKCa (AP14145) were used to compare the effects on ventricular and atrial repolarization. Ondansetron, which has been reported to be a potent blocker of both IKr and IKCa, was included to examine its potential atrial antiarrhythmic properties. >Experimental Approach: The expression of KCa2- and Kv11.1-channels in the guinea pig heart was investigated using quantitative polymerase chain reaction (qPCR). Whole-cell patch clamp technique was used to investigate the effects of dofetilide, AP14145, and ondansetron on IKCa and/or IKr. The effect of dofetilide, AP14145, and ondansetron on atrial and ventricular repolarization was investigated in isolated hearts. A novel atrial paced in vivo guinea pig model was further validated using AP14145 and dofetilide. >Key Results: AP14145 increased the atrial effective refractory period (AERP) without prolonging the QT interval with Bazett’s correction for heart rate (QTcB) both ex vivo and in vivo. In contrast, dofetilide increased QTcB and, to a lesser extent, AERP in isolated hearts and prolonged QTcB with no effects on AERP in the in vivo guinea pig model. Ondansetron did not inhibit IKCa, but did inhibit IKr in vitro. Ondansetron prolonged ventricular, but not atrial repolarization ex vivo. >Conclusion and Implications: IKCa inhibition by AP14145 selectively increases atrial repolarization, whereas IKr inhibition by dofetilide and ondansetron increases ventricular repolarization to a larger extent than atrial repolarization.
机译:>背景和目的:心脏活动电位的延长被认为在心房中有抗心律不齐的作用,但如果抑制Kv11.1通道(IKr)的电流,则在心室中有心律失常的可能。由KCa2通道介导的电流IKCa被认为是治疗房颤(AF)的有希望的新靶标。使用IKr(多非利特)和IKCa(AP14145)的选择性抑制剂来比较对心室和心房复极的影响。恩丹西酮,据报道是IKr和IKCa的强效阻滞剂,被包括在内以检查其潜在的心房抗心律失常特性。 >实验方法:使用定量聚合酶链反应(qPCR)研究了豚鼠心脏中KCa2-和Kv11.1通道的表达。使用全细胞膜片钳技术研究多非利特,AP14145和恩丹西酮对IKCa和/或IKr的影响。在离体心脏中研究了多非利特,AP14145和恩丹西酮对心房和心室复极的影响。使用AP14145和多非利特进一步验证了新型心房起搏的豚鼠体内模型。 >主要结果:AP14145延长了心房有效不应期(AERP),而无需延长QT间隔,而Bazett的离体和离体心率校正(QTcB)均如此。相反,多非利特在离体心脏中增加QTcB并在较小程度上增加AERP,而延长QTcB在体内豚鼠模型中对AERP无影响。恩丹西酮不抑制IKCa,但在体外却抑制IKr。恩丹西酮可延长心室,但离体不能使心房复极。 >结论与意义:AP14145对IKCa的抑制作用选择性地增加了心房复极,而多芬替利和恩丹西酮对IKr的抑制作用则比心房复极化更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号